The company was established in Asia in Israel. The leading representative office of defined Corporate Investor is situated in the Tel Aviv.
Opposing the other organizations, this Docor International Management works on 1 percentage points more the average amount of lead investments. Speaking about the real fund results, this Corporate Investor is 16 percentage points less often commits exit comparing to other organizations. The top activity for fund was in 2008. Despite it in 2019 the fund had an activity. Deals in the range of 5 - 10 millions dollars are the general things for fund. The higher amount of exits for fund were in 2010. The fund is generally included in less than 2 deals every year.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - Israel. Among the various public portfolio startups of the fund, we may underline MacroCure, MacroCure, Check-Cap The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Education, Health Care.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Docor International Management, startups are often financed by Pontifax, Pitango Venture Capital, iVentures Asia Ltd. The meaningful sponsors for the fund in investment in the same round are Pontifax, Pitango Venture Capital, iVentures Asia Ltd. In the next rounds fund is usually obtained by Pitango Venture Capital, Lord David Alliance, JK&B Capital.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Raziel Health | $22M | 18 Dec 2019 | Florida, United States | ||
SP Nano | $2M | 20 Jun 2014 | North District | ||
$3M | 24 Sep 2013 | New York, New York, United States | |||
SP Nano | $3M | 01 Jun 2012 | North District | ||
EarlySense | $13M | 23 Jul 2010 | Tel Aviv District | ||
$1M | 31 May 2010 | New York, New York, United States | |||
Fourier Education | $3M | 18 Mar 2008 | Orland Park, Illinois, United States | ||
MentorWave Technologies | $3M | 28 May 2007 | Tel Aviv District | ||
Protalix BioTherapeutics | $5M | 25 Dec 2005 | North District |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Raziel Health | $22M | 18 Dec 2019 | Florida, United States | ||
SP Nano | $2M | 20 Jun 2014 | North District | ||
$3M | 24 Sep 2013 | New York, New York, United States | |||
SP Nano | $3M | 01 Jun 2012 | North District | ||
EarlySense | $13M | 23 Jul 2010 | Tel Aviv District | ||
$1M | 31 May 2010 | New York, New York, United States | |||
Fourier Education | $3M | 18 Mar 2008 | Orland Park, Illinois, United States | ||
MentorWave Technologies | $3M | 28 May 2007 | Tel Aviv District | ||
Protalix BioTherapeutics | $5M | 25 Dec 2005 | North District |